June 15, 2007
Press Release no.1
Security listed and
admitted to dealings - NETFINCO
The
security of the following company shall be listed and admitted to
dealings on the Exchange w.e.f. June 19, 2007. Trading shall be in the Normal
Market Segment – Compulsory Demat (Rolling Settlement) for all investors.
Sr. No. |
Symbol |
Name of the Company |
ISIN Code |
1 |
NETFINCO |
Netflier Finco Limited |
INE068I01012 |
Press Release no.2
Security
listed and admitted to dealings - DECOLIGHT
The equity
shares of the following company shall be listed and admitted to dealings
on the Exchange w.e.f. June
19, 2007.
Trading shall be in the Normal Market segment – Compulsory Demat (Rolling
Settlement) for all investors.
Sr. No. |
Symbol |
Name of the Company |
ISIN Code |
1 |
DECOLIGHT |
Decolight Ceramics Limited |
INE172I01012 |
Press Release no.3
Security listed and
admitted to dealings - HTMTGLOBAL
The
security of the following company shall be listed and admitted to
dealings on the Exchange w.e.f. June 19, 2007. Trading shall be in the Normal
Market Segment – Compulsory Demat (Rolling Settlement) for all investors.
Sr. No. |
Symbol |
Name of the Company |
ISIN Code |
1 |
HTMTGLOBAL |
HTMT Global Solutions Limited |
INE170I01016 |
Press Release no.4
News about Aarti
Industries Limited
The media had reports that Aarti Industries Ltd. may
merge with Aarti Drugs Ltd. Further, a major drug maker may take up an equity
stake in the company.
The Exchange, in order to verify the accuracy or
otherwise of the information reported in the media and to inform the market
place so that the interest of the investors is safeguarded, had written to the
officials of the company.
Aarti Industries Ltd. has vide its letter inter-alia
stated," We seek to clarify that there is no such merger proposal under
active consideration of the management of both the companies. Further, as
regards reports on rumours of picking up equity stake by any drug major in the
Company, we deny the same as baseless rumour. Nevertheless, it is further
clarified that, consideration of any such merger proposal in future may not be
ruled out. The Company would certainly comply with all the disclosure
requirements applicable under the Listing Agreement in relation to any
proposals, which will be price sensitive."
Press Release no.5
News about Aarti Drugs
Limited
The media had reports that Aarti Drugs Ltd. may
merge with Aarti Industries Ltd. Further, a major drug maker may take up an
equity stake in the company.
The Exchange, in order to verify the accuracy or
otherwise of the information reported in the media and to inform the market
place so that the interest of the investors is safeguarded, had written to the
officials of the company.
Aarti Drugs Ltd. has vide its letter inter-alia
stated, "We seek to clarify that there is no such merger proposal under
active consideration of the management of both the companies. Further, as
regards reports on rumours of picking up equity stake by any drug major in the
Company, we deny the same as baseless rumour. Nevertheless, it is further
clarified that, consideration of any such merger proposal in future may not be
ruled out. The Company would certainly comply with all the disclosure
requirements applicable under the Listing Agreement in relation to any
proposals, which will be price sensitive."
Press Release no.6
NSE completes its 1833rd
Normal Settlement
The Exchange has successfully
completed its 1833rd Normal Settlements (Rolling T+2 following SEBI
directive) since inception i.e., Settlement Number N – 2007110 on June 15,
2007. The settlement statistics are as follows:
Particulars
|
Values
|
|
N – 2007110
|
Total traded quantity (lakhs) |
3131.92 |
Total traded value (Rs. In Crores) |
8190.71 |
Total value of the settlement (Securities) (Rs. In Crores) |
1987.93 |
Total value of the settlement (Funds) (Rs. In Crores) |
647.44 |
Shortages for the settlement
|
0.41% |
% of Delivery ( No. of
shares deliverable / No. of shares traded ) |
24.17% |
Retail Debt Market have completed its 1107th
settlements details of which are as follows:
Settlement No. |
Traded Value |
Settlement Value |
|
|
|
Securities |
Funds |
D- 2007110 |
NIL |
NIL |
NIL |